Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
Yucheng, CN
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. specializes in the manufacturing and global distribution of functional carbohydrates. The company's diverse product range includes various categories: Oligosaccharides: Offered in both powdered and liquid forms, such as oligofructose, isomalto oligosaccharide, xylo-oligosaccharides, and galactooligosaccharides. Dietary Fibers: Featuring ingredients like polydextrose and resistant dextrin. Sugar Alcohols: Encompassing crystalline maltitol and maltitol syrup. Starch Sugars: Including high fructose syrup, maltodextrin, and high maltose powder. Specialty Syrups: Formulations tailored for applications like mono cake, bakery, and bread products. Fermentation Products: A separate category of offerings. Established in 2005, the enterprise maintains its headquarters in Yucheng, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.14% | +1.83% | +2.30% | +15.06% | +29.77% | +31.57% | +52.55% | +135.85% | +213.00% | +244.07% | +244.07% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+19.8% ★ Q1'26: +25.3% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%+15.8% ★ Q1'26: +16.0% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+0.7% Q1'26: -2.8% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+31.8% ★ Q1'26: +36.2% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+22.5% ★ Q1'26: +25.5% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+30.0% Q1'26: +29.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.41× ★ Q1'26: 0.89× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
653.36M
est: 653.00M (+0.1%)
|
721.89M
est: 731.50M (-1.3%)
|
868.26M
est: 986.85M (-12.0%)
|
1.15B
est: 1.15B (0.0%)
|
1.38B
est: 1.38B (+0.0%)
|
1.72B
1.64B – 1.80B
+25.1% YoY
|
2.17B
2.07B – 2.34B
+26.1% YoY
|
2.75B
2.63B – 2.86B
+26.3% YoY
|
| EBITDA |
156.51M
est: 179.16M (-12.6%)
|
192.42M
est: 200.70M (-4.1%)
|
238.38M
est: 288.19M (-17.3%)
|
334.22M
est: 336.36M (-0.6%)
|
536.86M
est: 402.71M (+33.3%)
|
503.67M
480.12M – 524.36M
+25.1% YoY
|
634.92M
603.62M – 684.54M
+26.1% YoY
|
802.09M
768.18M – 836.00M
+26.3% YoY
|
| EBIT |
109.98M
est: 134.88M (-18.5%)
|
145.68M
est: 151.09M (-3.6%)
|
193.45M
est: 224.08M (-13.7%)
|
258.84M
est: 261.54M (-1.0%)
|
438.05M
est: 313.13M (+39.9%)
|
391.63M
373.31M – 407.71M
+25.1% YoY
|
493.68M
469.34M – 532.26M
+26.1% YoY
|
623.66M
597.29M – 650.02M
+26.3% YoY
|
| Net Income |
104.48M
est: 80.97M (+29.0%)
|
150.75M
est: 118.83M (+26.9%)
|
193.00M
est: 290.32M (-33.5%)
|
245.60M
est: 251.60M (-2.4%)
|
368.55M
est: 372.83M (-1.1%)
|
486.47M
481.23M – 493.78M
+30.5% YoY
|
616.25M
610.55M – 653.55M
+26.7% YoY
|
760.94M
707.56M – 915.40M
+23.5% YoY
|
| SGA |
40.35M
est: 39.54M (+2.0%)
|
45.05M
est: 44.29M (+1.7%)
|
47.77M
est: 51.94M (-8.0%)
|
67.54M
est: 60.62M (+11.4%)
|
34.90M
est: 72.57M (-51.9%)
|
90.77M
86.52M – 94.49M
+25.1% YoY
|
114.42M
108.78M – 123.36M
+26.1% YoY
|
144.54M
138.43M – 150.66M
+26.3% YoY
|
| EPS |
0.42
est: 0.25 (+67.6%)
|
0.61
est: 0.37 (+65.9%)
|
0.60
est: 0.69 (-12.4%)
|
0.76
est: 0.59 (+28.0%)
|
0.88
est: 0.88 (+0.0%)
|
1.16
1.15 – 1.18
+31.3% YoY
|
1.50
1.45 – 1.56
+29.9% YoY
|
1.91
1.68 – 2.18
+26.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck - China New Economy ETF CNEW.AX | 0.78% | 552.7K | 0.95% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anguo Zhang | Deputy General Manager | — | male |
| Dexuan Zhao | Deputy General Manager | — | male |
| Guangpeng Dou | Deputy General Manager | — | male |
| Hongjian Zhuo | GM & Director | — | male |
| Jun Wei | Deputy General Manager | — | male |
| Junchao Gu | Board Secretary | — | male |
| Li Li | Chief Financial Officer | — | female |
| Mingjing Shang | Accounting Supervisor | — | — |
| Wenping Yu | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 605016.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
